SLGL

79.46

4.84% -4.04

Dopo l'orario di chiusura: 78.99 -0.47 -0.59%

Sol Gel Technologies Ltd (SLGL)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Forum Previsione

Precedente Chiudi:

$83.50

Aprire:

$82.9

Volume 24 ore:

80,092

Relative Volume:

2.52

Capitalizzazione di mercato:

$257.87M

Reddito:

$19.39M

Utile/perdita netta:

$-6.13M

Rapporto P/E:

-36.13

EPS:

-2.1994

Flusso di cassa netto:

$-33.87M

1 W Prestazione:

+2.20%

1M Prestazione:

-13.23%

6M Prestazione:

+169.36%

1 anno Prestazione:

+1,542%

Intervallo 1D:

$77.46

$84.60

Intervallo di 1 settimana:

$65.07

$85.33

Portata 52W:

$4.018

$97.97

Sol Gel Technologies Ltd Stock (SLGL) Company Profile

Nome

Sol Gel Technologies Ltd

Settore

Healthcare (1118)

Industria

Biotechnology (624)

Telefono

Indirizzo

Dipendente

Cinguettio

Prossima data di guadagno

2025-08-15

Ultimi documenti SEC

SLGL's Discussions on Twitter

Compare SLGL vs VRTX, REGN, ARGX, ALNY, INSM

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
SLGL Sol Gel Technologies Ltd	79.46	257.87M	19.39M	-6.13M	-33.87M	-2.1994
VRTX Vertex Pharmaceuticals Inc	438.71	111.45B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	761.85	80.54B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	746.42	46.32B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	318.85	42.29B	3.71B	313.75M	465.38M	2.2571
INSM Insmed Inc	162.43	35.01B	606.42M	-1.28B	-997.58M	-6.403

Sol Gel Technologies Ltd Stock (SLGL) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-08-19	Downgrade	Raymond James	Strong Buy → Outperform
2022-10-21	Ripresa	Jefferies	Hold
2019-12-31	Reiterato	H.C. Wainwright	Buy
2019-12-31	Reiterato	JMP Securities	Mkt Outperform

Sol Gel Technologies Ltd Borsa (SLGL) Ultime notizie

Apr 04, 2026

SLGL PE Ratio & Valuation, Is SLGL Overvalued - Intellectia AI

Apr 04, 2026

Apr 03, 2026

Cash per share of Sol-Gel Technologies Ltd. – SWB:4SG - TradingView

Apr 03, 2026

Mar 31, 2026

Sol-Gel Technologies Completes $33.1 Million Underwritten Share Offering - Global Legal Chronicle

Mar 31, 2026

Great Point Partners, Dr. Jay & Nordahl disclose 8.45% stake in Sol-Gel (SLGL) - Stock Titan

Mar 31, 2026

Growth Review: Is Sol Gel Technologies Ltd impacted by rising rates2026 Short Interest & Safe Entry Point Alerts - baoquankhu1.vn

Mar 26, 2026

Mar 24, 2026

Sol-Gel Technologies Prices $33.1 Million Oversubscribed Equity Offering to Advance SGT-610 - tipranks.com

Mar 24, 2026

Sol-Gel (NASDAQ: SLGL) prices $33.1M oversubscribed share offering - Stock Titan

Mar 24, 2026

Sol‑Gel (NASDAQ: SLGL) raises ~$30.8M via 459,112‑share offering to fund SGT‑610 - Stock Titan

Mar 24, 2026

Opaleye Management (SLGL) linked entities buy 39,665 Sol-Gel shares - Stock Titan

Mar 24, 2026

12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga

Mar 24, 2026

Sol-Gel Technologies (SLGL) Prices Oversubscribed Offering, Shar - GuruFocus

Mar 24, 2026

SLGL Announces Offering with TD Cowen and LifeSci Capital as Man - GuruFocus

Mar 24, 2026

[EFFECT] Sol-Gel Technologies Ltd. SEC Filing - Stock Titan

Mar 24, 2026

Mar 23, 2026

Sol-Gel Technologies Ltd. Announces Pricing of Oversubscribed Underwritten Offering - weeklyvoice.com

Mar 23, 2026

Sol-Gel brings in $33.1M to fund SGT-610 development - Stock Titan

Mar 23, 2026

Sol-Gel Technologies Ltd. announces pricing of oversubscribed underwritten offering - MarketScreener

Mar 23, 2026

Sol-Gel Technologies Ltd. Announces Pricing of $33.1 Million Underwritten Offering of Ordinary Shares - Quiver Quantitative

Mar 23, 2026

Sol-Gel Technologies Ltd. Announces Pricing Of Oversubscribed Underwritten Offering - TradingView

Mar 23, 2026

Sol-Gel Technologies Ltd. Announces Pricing of Oversubscribed Underwritten Offering - GlobeNewswire Inc.

Mar 23, 2026

Opaleye (SLGL) affiliate discloses 460,335 shares, 16.52% stake - Stock Titan

Mar 23, 2026

Mar 22, 2026